/
/
/

Gufic Biosciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹261 Cr₹252 Cr₹231 Cr₹237 Cr₹224 Cr₹205 Cr₹208 Cr₹204 Cr₹203 Cr₹195 Cr₹202 Cr₹215 Cr
₹46 L-₹1 Cr₹79 L₹2 Cr₹93 L₹39 L₹2 Cr₹11 L₹1 Cr₹88 L₹42 L₹33 L
₹261 Cr₹251 Cr₹232 Cr₹239 Cr₹225 Cr₹205 Cr₹210 Cr₹204 Cr₹204 Cr₹196 Cr₹202 Cr₹215 Cr
₹222 Cr₹212 Cr₹206 Cr₹207 Cr₹198 Cr₹186 Cr₹178 Cr₹170 Cr₹171 Cr₹165 Cr₹169 Cr₹180 Cr
₹47 Cr₹46 Cr₹34 Cr₹40 Cr₹34 Cr₹27 Cr₹36 Cr₹39 Cr₹37 Cr₹35 Cr₹37 Cr₹40 Cr
₹9 Cr₹9 Cr₹8 Cr₹10 Cr₹9 Cr₹8 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr
₹30 Cr₹29 Cr₹18 Cr₹23 Cr₹17 Cr₹11 Cr₹26 Cr₹29 Cr₹28 Cr₹27 Cr₹30 Cr₹31 Cr
₹22 Cr₹22 Cr₹12 Cr₹17 Cr₹13 Cr₹8 Cr₹19 Cr₹22 Cr₹21 Cr₹20 Cr₹22 Cr₹23 Cr

Share Price Live Stats

Open (₹)418.90
Volume (₹)6,577.00
High (₹)423.10
Upper Circuit499.80
Low (₹)413.45
Lower Circuit333.20
Prev Close416.50
52W High (₹)467.80
Price421.50
52W Low (₹)268.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4185.29 Cr
Div. Yield (%)0.02
PE Ratio56.98
Debt to Equity0.58
Price to Book4.14
Book Value66.31
EPS (TTM)7.33
Face Value1.00
ROE (%)10.14

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
GUFICBIONSE
LTP
1W Low
1W High
Market cap (₹)
1782.9+5.2 (0.29%)
1722
1796.60
4,25,150Cr
9988+208 (2.13%)
9863
10067
2,66,265Cr
4644.8+31.4 (0.68%)
4553
4675
1,76,301Cr
2309-96.5 (-4.01%)
2252.40
2441.90
1,25,352Cr
1259.6+14.1 (1.13%)
1217.20
1262.50
1,23,591Cr
1371.1+19.1 (1.41%)
1336.70
1376.70
1,14,351Cr
1389.9+11 (0.80%)
1364.60
1400.80
1,12,474Cr
2496.3+3.5 (0.14%)
2457.90
2512.30
1,02,315Cr
1693.1+11.7 (0.70%)
1656.20
1708.80
97,757Cr
2023.5+12.5 (0.62%)
1988.90
2062.10
92,007Cr
421.5+7.95 (1.92%)
408.65
427.50
4,185Cr

Key Highlights of Gufic Biosciences Ltd’s P&L

In 2026-03-31, Gufic Biosciences Ltd reported total revenue of ₹946.66Cr, compared with ₹823.43Cr in 2025-03-31, reflecting Gufic Biosciences Ltd turnover.

Depreciation was ₹30.83Cr and finance costs were ₹36.61Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹86.55Cr in 2026-03-31 as compared to ₹94.14Cr in 2025-03-31.

Net Profit (PAT) was ₹64.21Cr in 2026-03-31 compared with ₹69.65Cr in 2025-03-31.

Earnings per share (EPS) were ₹6.40 in 2026-03-31, compared with ₹6.95 in 2025-03-31.